REQUEST A DEMO
Total
USD $0.00
Search more companies

Rifarm-M OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Rifarm-M OOO Profile Updated: September 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Rifarm-M OOO is a company based in Russia, with its head office in Chelyabinsk. It operates in the Pharmacies and Drug Stores sector. It was incorporated on July 08, 2008. It currently has a total number of 9 (2022) employees. The company’s latest financial report indicates a net sales revenue drop of 15% in 2022. Its’ total assets recorded a growth of 24.12%.

Headquarters
Grazhdanskaya, 10, 1
Chelyabinsk; Chelyabinsk Oblast; Postal Code: 454078

Contact Details: Purchase the Rifarm-M OOO report to view the information.

Basic Information
Total Employees:
Purchase the Rifarm-M OOO report to view the information.
Outstanding Shares:
Purchase the Rifarm-M OOO report to view the information.
Registered Capital:
Purchase the Rifarm-M OOO report to view the information.
Incorporation Date:
July 08, 2008
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Rifarm-M OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-15%
Total operating revenue
-15%
Operating profit (EBIT)
14.67%
Net Profit (Loss) for the Period
0%
Total assets
24.12%
Total equity
0.08%
Operating Profit Margin (ROS)
-0.02%
Return on Equity (ROE)
0%
Quick Ratio
-0.17%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?